Pegylated Interferon Alpha 2B

Pegylated Interferon Alpha 2B is a synthetic version of a protein called interferon, which is naturally produced by the body to help fight viral infections. This medication is pegylated, meaning a polymer (peg) has been attached to the interferon, allowing it to have a longer-lasting effect in the body.
Pegylated Interferon Alpha 2B is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. The goal of treatment is to eliminate the virus from the body and prevent liver damage, which can potentially lead to liver failure or liver cancer. This medication works by boosting the body’s immune system and directly inhibiting the replication of the hepatitis C virus.
Pegylated Interferon Alpha 2B is typically administered through a series of subcutaneous injections, usually once a week, in combination with other antiviral medications, such as ribavirin. The duration of treatment may vary depending on the severity of the infection and the specific genotype of the hepatitis C virus.
The use of Pegylated Interferon Alpha 2B may be associated with several side effects, including flu-like symptoms, fatigue, depression, and injection site reactions. Patients should consult with their healthcare provider about the potential risks and benefits of this medication before initiating treatment.